CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 56 filers reported holding CASI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $12,000 | -33.3% | 15,090 | 0.0% | 0.01% | -16.7% |
| Q3 2021 | $18,000 | -21.7% | 15,090 | 0.0% | 0.01% | -14.3% |
| Q2 2021 | $23,000 | 0.0% | 15,090 | 0.0% | 0.01% | -36.4% |
| Q3 2020 | $23,000 | -39.5% | 15,090 | 0.0% | 0.01% | -50.0% |
| Q2 2020 | $38,000 | -45.7% | 15,090 | 0.0% | 0.02% | -15.4% |
| Q3 2018 | $70,000 | -43.5% | 15,090 | 0.0% | 0.03% | -48.0% |
| Q2 2018 | $124,000 | +359.3% | 15,090 | 0.0% | 0.05% | +284.6% |
| Q3 2017 | $27,000 | +68.8% | 15,090 | 0.0% | 0.01% | +62.5% |
| Q2 2017 | $16,000 | -23.8% | 15,090 | 0.0% | 0.01% | -11.1% |
| Q1 2017 | $21,000 | +23.5% | 15,090 | 0.0% | 0.01% | +28.6% |
| Q3 2016 | $17,000 | -5.6% | 15,090 | 0.0% | 0.01% | -12.5% |
| Q2 2016 | $18,000 | +12.5% | 15,090 | 0.0% | 0.01% | +33.3% |
| Q1 2016 | $16,000 | 0.0% | 15,090 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $16,000 | -40.7% | 15,090 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $27,000 | 0.0% | 15,090 | 0.0% | 0.01% | +33.3% |
| Q3 2014 | $27,000 | – | 15,090 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wellington Shields & Co., LLC | 951,064 | $7,827,000 | 4.06% |
| Wellington Shields Capital Management, LLC | 855,056 | $7,037,000 | 1.16% |
| Manatuck Hill Partners, LLC | 15,090 | $124,000 | 0.05% |
| Moors & Cabot, Inc. | 22,935 | $187,000 | 0.02% |
| Perceptive Advisors | 43,682 | $360,000 | 0.01% |
| ROYCE & ASSOCIATES LP | 120,000 | $988,000 | 0.01% |
| ALPS ADVISORS INC | 125,015 | $1,029,000 | 0.01% |
| MetLife Investment Management, LLC | 26,316 | $217,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 136,518 | $1,124,000 | 0.00% |
| Private Advisor Group, LLC | 15,001 | $122,000 | 0.00% |